Overall patient survival assessed with Cox proportional hazard models, adjusted for stage, indicated that BRAF mutant/MSS cancers with CIN at the 18q and 5q loci, conferred significantly poorer outcomes compared to those BRAF mutant/MSS cancers without CIN at these loci (Table 5). Here, BRAF is linked to cancer.